{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:17:38Z","timestamp":1783487858041,"version":"3.55.0"},"reference-count":28,"publisher":"Japan Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1507\/endocrj.ej19-0067","type":"journal-article","created":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T22:05:23Z","timestamp":1558476323000},"page":"739-744","source":"Crossref","is-referenced-by-count":7,"title":["A novel case of myxoid variant of adrenocortical carcinoma in a patient with multiple endocrine neoplasia type 1"],"prefix":"10.1507","volume":"66","author":[{"given":"Ko","family":"Harada","sequence":"first","affiliation":[{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kou","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology, Tohoku University Graduate School of Medicine, Miyagi 980-8575, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Sasano","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology, Tohoku University Graduate School of Medicine, Miyagi 980-8575, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Otsuka","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Fassnacht M, Kroiss M, Allolio B (2013) Update in adrenocortical carcinoma. J Clin Endocrinol Metab 98: 4551\u20134564.","DOI":"10.1210\/jc.2013-3020"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Allolio B, Fassnacht M (2006) Clinical review: adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 91: 2027\u20132037.","DOI":"10.1210\/jc.2005-2639"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Ng L, Libertino JM (2003) Adrenocortical carcinoma: diagnosis, evaluation and treatment. J Urol 169: 5\u201311.","DOI":"10.1016\/S0022-5347(05)64023-2"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 de Krijger RR, Papathomas TG (2012) Adrenocortical neoplasia: evolving concepts in tumorigenesis with an emphasis on adrenal cortical carcinoma variants. Virchows Arch 460: 9\u201318.","DOI":"10.1007\/s00428-011-1166-y"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Veytsman I, Nieman L, Fojo T (2009) Management of endocrine manifestations and the use of mitotane as a chemotherapeutic agent for adrenocortical carcinoma. J Clin Oncol 27: 4619\u20134629.","DOI":"10.1200\/JCO.2008.17.2775"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Balasubramaniam S, Fojo T (2010) Practical considerations in the evaluation and management of adrenocortical cancer. Semin Oncol 37: 619\u2013626.","DOI":"10.1053\/j.seminoncol.2010.10.011"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Duregon E, Cappellesso R, Maffeis V, Zaggia B, Ventura L, et al. (2017) Validation of the prognostic role of the \u201cHelsinki Score\u201d in 225 cases of adrenocortical carcinoma. Hum Pathol 62: 1\u20137.","DOI":"10.1016\/j.humpath.2016.09.035"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Weissferdt A, Phan A, Suster S, Moran CA (2013) Myxoid adrenocortical carcinoma: a clinicopathologic and immunohistochemical study of 7 cases, including 1 case with lipomatous metaplasia. Am J Clin Pathol 139: 780\u2013786.","DOI":"10.1309\/AJCPCDZLC13RSXRZ"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Sung TY, Choi YM, Kim WG, Lee YM, Kim TY, et al. (2017) Myxoid and sarcomatoid variants of adrenocortical carcinoma: analysis of rare variants in single tertiary care center. J Korean Med Sci 32: 764\u2013771.","DOI":"10.3346\/jkms.2017.32.5.764"},{"key":"10","unstructured":"10 Busygina V, Bale AE (2006) Multiple endocrine neoplasia type 1 (MEN1) as a cancer predisposition syndrome: clues into the mechanisms of MEN1-related carcinogenesis. Yale J Biol Med 79: 105\u2013114."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, et al. (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276: 404\u2013407.","DOI":"10.1126\/science.276.5311.404"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Griniatsos JE, Dimitriou N, Zilos A, Sakellariou S, Evangelou K, et al. (2011) Bilateral adrenocortical carcinoma in a patient with multiple endocrine neoplasia type 1 (MEN1) and a novel mutation in the MEN1 gene. World J Surg Oncol 9: 6.","DOI":"10.1186\/1477-7819-9-6"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Gatta-Cherifi B, Chabre O, Murat A, Niccoli P, Cardot-Bauters C, et al. (2012) Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d\u2019etude des Tumeurs Endocrines database. Eur J Endocrinol 166: 269\u2013279.","DOI":"10.1530\/EJE-11-0679"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Mazzuco TL, Durand J, Chapman A, Crespigio J, Bourdeau I (2012) Genetic aspects of adrenocortical tumours and hyperplasias. Clin Endocrinol (Oxf) 77: 1\u201310.","DOI":"10.1111\/j.1365-2265.2012.04403.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Sakurai A, Imai T, Kikumori T, Horiuchi K, Okamoto T, et al. (2013) Thymic neuroendocrine tumour in multiple endocrine neoplasia type 1: female patients are not rare exceptions. Clin Endocrinol (Oxf) 78: 248\u2013254.","DOI":"10.1111\/j.1365-2265.2012.04467.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 van Leeuwaarde RS, Dreijerink KM, Ausems MG, Beijers HJ, Dekkers OM, et al. (2017) MEN1-dependent breast cancer: indication for early screening? Results from the Dutch MEN1 Study Group. J Clin Endocrinol Metab 102: 2083\u20132090.","DOI":"10.1210\/jc.2016-3690"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Jeong YJ, Oh HK, Bong JG (2014) Multiple endocrine neoplasia type 1 associated with breast cancer: a case report and review of the literature. Oncol Lett 8: 230\u2013234.","DOI":"10.3892\/ol.2014.2144"},{"key":"18","unstructured":"18 Ohara N, Kaneko M, Ikeda M, Ishizaki F, Suzuki K, et al. (2017) Lung adenocarcinoma and adrenocortical carcinoma in a patient with multiple endocrine neoplasia type 1. Respir Med Case Rep 20: 77\u201381."},{"key":"19","unstructured":"19 Tang CK, Harriman BB, Toker C (1979) Myxoid adrenal cortical carcinoma: a light and electron microscopic study. Arch Pathol Lab Med 103: 635\u2013638."},{"key":"20","unstructured":"20 Lloyd RV, Osamura RY, Kl\u00f6ppel G, Rosai J, Bosman FT, <i>et al.<\/i> (2017) WHO classification of tumours of endocrine organs. World Health Organization Classification of Tumours: 355 pages."},{"key":"21","doi-asserted-by":"publisher","unstructured":"21 Erickson LA (2018) Challenges in surgical pathology of adrenocortical tumours. Histopathology 72: 82\u201396.","DOI":"10.1111\/his.13255"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Miyoshi T, Otsuka F, Suzuki J, Inagaki K, Kano Y, et al. (2005) Abrupt enlargement of adrenal incidentaloma: a case of isolated adrenal metastasis. Endocr J 52: 785\u2013788.","DOI":"10.1507\/endocrj.52.785"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Abiven G, Coste J, Groussin L, Anract P, Tissier F, et al. (2006) Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. J Clin Endocrinol Metab 91: 2650\u20132655.","DOI":"10.1210\/jc.2005-2730"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, et al. (2012) Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 97: 2990\u20133011.","DOI":"10.1210\/jc.2012-1230"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Marini F, Giusti F, Tonelli F, Brandi ML (2017) Management impact: effects on quality of life and prognosis in MEN1. Endocr Relat Cancer 24: T227\u2013T242.","DOI":"10.1530\/ERC-17-0203"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Bharwani N, Rockall AG, Sahdev A, Gueorguiev M, Drake W, et al. (2011) Adrenocortical carcinoma: the range of appearances on CT and MRI. AJR Am J Roentgenol 196: W706\u2013W714.","DOI":"10.2214\/AJR.10.5540"},{"key":"27","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.4081\/rt.2013.e54","volume":"5","author":"H Fukuhara","year":"2013","unstructured":"27 Fukuhara H, Bilim V, Ohtake H, Yahagi Y, Tomita Y (2013) A case of myxoid adrenocortical neoplasm: computed tomography and magnetic resonance imaging characteristics. Rare Tumors 5: e54.","journal-title":"Rare Tumors","ISSN":"https:\/\/id.crossref.org\/issn\/2036-3605","issn-type":"print"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Kim TU, Kim S, Lee JW, Lee NK, Ha HK, et al. (2014) Myxoid adrenocortical adenoma: magnetic resonance imaging and pathology correlation. Korean J Radiol 15: 245\u2013249.","DOI":"10.3348\/kjr.2014.15.2.245"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/66\/8\/66_EJ19-0067\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T03:43:01Z","timestamp":1567222981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/66\/8\/66_EJ19-0067\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej19-0067","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}